These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 23835667

  • 1. Cystatin C associates with the prediction of in-stent restenosis among patients receiving stent implantation: results of the 1-year follow-up.
    Zhao C, Yang L, Mao L, Zhong L, Li X, Wei S.
    Coron Artery Dis; 2013 Aug; 24(5):357-60. PubMed ID: 23835667
    [Abstract] [Full Text] [Related]

  • 2. Role of red blood cell distribution in predicting drug-eluting stent restenosis in patients with stable angina pectoris after coronary stenting.
    Zhao K, Li YJ, Gao S.
    Coron Artery Dis; 2015 May; 26(3):220-4. PubMed ID: 25647458
    [Abstract] [Full Text] [Related]

  • 3. Association of high level of hs-CRP with in-stent restenosis: A case-control study.
    Baktashian M, Saffar Soflaei S, Kosari N, Salehi M, Khosravi A, Ahmadinejad M, Moohebati M, Ebrahimi M, Rahmani F, Khameneh-Bagheri R, Ahmadi M, Sadabadi F, Tayefi M, Bazhdanzadeh S, Ferns GA, Hashemi SM, Pasdar A, Ghayour-Mobarhan M.
    Cardiovasc Revasc Med; 2019 Jul; 20(7):583-587. PubMed ID: 30232022
    [Abstract] [Full Text] [Related]

  • 4. Influence of insulin resistance on in-stent restenosis in patients undergoing coronary drug-eluting stent implantation after long-term angiographic follow-up.
    Zhao LP, Xu WT, Wang L, Li H, Shao CL, Gu HB, Chan SP, Xu HF, Yang XJ.
    Coron Artery Dis; 2015 Jan; 26(1):5-10. PubMed ID: 25211654
    [Abstract] [Full Text] [Related]

  • 5. Effectiveness of everolimus-eluting stents in the treatment of drug-eluting stent versus bare-metal stent restenosis.
    Almalla M, Pross V, Marx N, Hoffmann R.
    Coron Artery Dis; 2012 Nov; 23(7):492-6. PubMed ID: 22990414
    [Abstract] [Full Text] [Related]

  • 6. Factors Influencing Stent Restenosis After Percutaneous Coronary Intervention in Patients with Coronary Heart Disease: A Clinical Trial Based on 1-Year Follow-Up.
    Cheng G, Chang FJ, Wang Y, You PH, Chen HC, Han WQ, Wang JW, Zhong NE, Min ZQ.
    Med Sci Monit; 2019 Jan 08; 25():240-247. PubMed ID: 30617247
    [Abstract] [Full Text] [Related]

  • 7. Risk factors for revascularization and in-stent restenosis in patients with triple-vessel disease after second-generation drug-eluting stent implantation: a retrospective analysis.
    Zeng M, Yan X, Wu W.
    BMC Cardiovasc Disord; 2021 Sep 17; 21(1):446. PubMed ID: 34535088
    [Abstract] [Full Text] [Related]

  • 8. Predictors for functionally significant in-stent restenosis: an integrated analysis using coronary angiography, IVUS, and myocardial perfusion imaging.
    Kang SJ, Cho YR, Park GM, Ahn JM, Han SB, Lee JY, Kim WJ, Park DW, Lee SW, Kim YH, Lee CW, Park SW, Mintz GS, Park SJ.
    JACC Cardiovasc Imaging; 2013 Nov 17; 6(11):1183-90. PubMed ID: 24229771
    [Abstract] [Full Text] [Related]

  • 9. Plasma levels of C-reactive protein and interleukin-10 predict late coronary in-stent restenosis 6 months after elective stenting.
    Zurakowski A, Wojakowski W, Dzielski T, Milewski K, Gościńska-Bis K, Tendera M, Buszman P.
    Kardiol Pol; 2009 Jun 17; 67(6):623-30. PubMed ID: 19618318
    [Abstract] [Full Text] [Related]

  • 10. Coronary CT angiography-derived quantitative markers for predicting in-stent restenosis.
    Tesche C, De Cecco CN, Vliegenthart R, Duguay TM, Stubenrauch AC, Rosenberg RD, Varga-Szemes A, Bayer RR, Yang J, Ebersberger U, Baquet M, Jochheim D, Hoffmann E, Steinberg DH, Chiaramida SA, Schoepf UJ.
    J Cardiovasc Comput Tomogr; 2016 Jun 17; 10(5):377-83. PubMed ID: 27431607
    [Abstract] [Full Text] [Related]

  • 11. Preprocedural red blood cell distribution width predicts bare metal stent restenosis.
    Yildiz A, Tekiner F, Karakurt A, Sirin G, Duman D.
    Coron Artery Dis; 2014 Sep 17; 25(6):469-73. PubMed ID: 24614629
    [Abstract] [Full Text] [Related]

  • 12. Intravascular ultrasound assessment of optimal stent area to prevent in-stent restenosis after zotarolimus-, everolimus-, and sirolimus-eluting stent implantation.
    Song HG, Kang SJ, Ahn JM, Kim WJ, Lee JY, Park DW, Lee SW, Kim YH, Lee CW, Park SW, Park SJ.
    Catheter Cardiovasc Interv; 2014 May 01; 83(6):873-8. PubMed ID: 22815193
    [Abstract] [Full Text] [Related]

  • 13. Baseline C-reactive protein serum levels and in-stent restenosis pattern after m-TOR inhibitors drug-eluting stent implantation.
    Niccoli G, Conte M, Cosentino N, Todaro D, Brugaletta S, Montone RA, Minelli S, Fracassi F, Galiffa V, Leone AM, Burzotta F, Porto I, Trani C, Crea F.
    J Invasive Cardiol; 2011 Jan 01; 23(1):16-20. PubMed ID: 21183765
    [Abstract] [Full Text] [Related]

  • 14. Clinical presentation and outcomes of coronary in-stent restenosis across 3-stent generations.
    Magalhaes MA, Minha S, Chen F, Torguson R, Omar AF, Loh JP, Escarcega RO, Lipinski MJ, Baker NC, Kitabata H, Ota H, Suddath WO, Satler LF, Pichard AD, Waksman R.
    Circ Cardiovasc Interv; 2014 Dec 01; 7(6):768-76. PubMed ID: 25466551
    [Abstract] [Full Text] [Related]

  • 15. Impact of coronary anatomy and stenting technique on long-term outcome after drug-eluting stent implantation for unprotected left main coronary artery disease.
    Tiroch K, Mehilli J, Byrne RA, Schulz S, Massberg S, Laugwitz KL, Vorpahl M, Seyfarth M, Kastrati A, ISAR-LEFT MAIN Study Investigators.
    JACC Cardiovasc Interv; 2014 Jan 01; 7(1):29-36. PubMed ID: 24332416
    [Abstract] [Full Text] [Related]

  • 16. Association between inflammatory biomarkers and in-stent restenosis tissue features: an Optical Coherence Tomography Study.
    Niccoli G, Dato I, Imaeva AE, Antonazzo Panico R, Roberto M, Burzotta F, Aurigemma C, Trani C, Gramegna M, Leone AM, Porto I, Crea F.
    Eur Heart J Cardiovasc Imaging; 2014 Aug 01; 15(8):917-25. PubMed ID: 24618655
    [Abstract] [Full Text] [Related]

  • 17. The neutrophil-to-lymphocyte ratio is associated with bare-metal stent restenosis in STEMI patients treated with primary PCI.
    Bolca O, Güngör B, Özcan KS, Karadeniz FÖ, Sungur A, Köroğlu B, Bakhshyaliyev N, Yelgeç NS, Karataş B, İpek G, Yilmaz H, Öztürk R.
    Coron Artery Dis; 2015 Aug 01; 26(5):402-8. PubMed ID: 25919903
    [Abstract] [Full Text] [Related]

  • 18. Different impacts of C-reactive protein and lipid profile on coronary lesions following a percutaneous coronary intervention.
    Xu HY, Qiao SB, Zhang JF, Dong QT, Li JJ.
    Coron Artery Dis; 2012 May 01; 23(3):181-7. PubMed ID: 22336660
    [Abstract] [Full Text] [Related]

  • 19. Visit-to-visit HbA1c variability is associated with in-stent restenosis in patients with type 2 diabetes after percutaneous coronary intervention.
    Yang CD, Shen Y, Lu L, Yang ZK, Hu J, Zhang RY, Shen WF, Ding FH, Wang XQ.
    Cardiovasc Diabetol; 2020 Sep 04; 19(1):133. PubMed ID: 32887588
    [Abstract] [Full Text] [Related]

  • 20. The characteristics and risk factors of in-stent restenosis in patients with percutaneous coronary intervention: what can we do.
    Wang P, Qiao H, Wang R, Hou R, Guo J.
    BMC Cardiovasc Disord; 2020 Dec 04; 20(1):510. PubMed ID: 33276720
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.